Literature DB >> 23793824

Lentinan: clinical benefit in the management of systemic malignancies.

Shailendra Kapoor1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793824     DOI: 10.1007/s00595-013-0641-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


× No keyword cloud information.
  5 in total

1.  Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer.

Authors:  Kyoko Shimizu; Shinya Watanabe; Seiji Watanabe; Kenji Matsuda; Tetsuya Suga; Saburo Nakazawa; Keiko Shiratori
Journal:  Hepatogastroenterology       Date:  2009 Jan-Feb

2.  Giant Krukenberg tumor from a perforated gastric cancer that was successfully removed after multidisciplinary therapy: report of a case.

Authors:  Masaki Sunagawa; Masatoshi Isogai; Tohru Harada; Yuji Kaneoka; Keitaro Kamei; Atsuyuki Maeda; Yuichi Takayama
Journal:  Surg Today       Date:  2012-09-18       Impact factor: 2.549

3.  Combination therapy with lentinan improves outcomes in patients with esophageal carcinoma.

Authors:  Ji-Lian Wang; Zheng Bi; Jian-Wen Zou; Xiao-Meng Gu
Journal:  Mol Med Rep       Date:  2011-12-19       Impact factor: 2.952

4.  Lentinan: hematopoietic, immunological, and efficacy studies in a syngeneic model of acute myeloid leukemia.

Authors:  Emmet McCormack; Jørn Skavland; Maja Mujic; Øystein Bruserud; Bjørn Tore Gjertsen
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

5.  Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patients with hepatocellular carcinoma.

Authors:  Norio Isoda; Yuichiro Eguchi; Haruhiko Nukaya; Keiko Hosho; Yasuyo Suga; Tetsuya Suga; Saburo Nakazawa; Kentaro Sugano
Journal:  Hepatogastroenterology       Date:  2009 Mar-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.